The long-term efficacy of recombinant hepatitis B vaccines for children
- VernacularTitle:重组乙肝疫苗免疫持久性观察
- Author:
Xiao-Lian DONG
1
;
Xue-Cai WANG
;
Ying-Feng CHEN
;
Sheng-Yu CHEN
;
Xiao-Li WANG
;
Jian-Liang FAN
;
Ying-Jie ZHENG
;
Zhi-Feng TANG
Author Information
1. 德清县疾病预防控制中心
- Keywords:
Hepatitis B vaccines;
Hepatitis B antibodies;
Booster immunization;
Long-term efficacy
- From:
Journal of Preventive Medicine
2014;(6):548-551
- CountryChina
- Language:Chinese
-
Abstract:
Objective To observe long-term efficacy of recombinant hepatitis B vaccines for children received fundamental immunization or booster dose. Methods 493 school students from Deqing county with complete information of immunization history were investigated and their serological markers were detected. 430 students received booster dose vaccines at 3-11 years old and were defined as booster group while the remaining 63 students were defined as fundamental group. Results All vaccines the 493 students received for fundamental immunization were recombinant. Compared with fundamental group(57. 14%),booster group had significantly higher Anti-HBs positive rate of 91. 40%(P<0. 01). And the Anti-HBs positive rate had a high level of 94. 99% when 0-5 years after booster immunization while it declined to 64. 71% after 8-15 years and showed no significant difference compared with fundamental group. Conclusion Anti-HBs level and anti -HBs positive rate can significantly increase for short periods after booster immunization,and may decline considerably for long-term. Immunologic amnesia rate is low when 3 -11 years after fundamental immunization among infants.
